Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GLAS · against 260 other Healthcare companies of similar size
Ranked #157 of 261 · scores higher than 39% of peers
Bars: peers in each 10-point band of the profitability score31 peers with a profitability score of 20–29, including GLAS · Click a bar to see the companies
Mainly because of its return on assets, return on invested capital and operating margin, which are weaker than most Healthcare peers.
| Metric | GLAS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 222 reported | -10.9% | -1.6% | 38% | 33% | |
| Operating marginHigher is better · 242 reported | -9.1% | 1.6% | 37% | 33% | |
| Return on assetsHigher is better · 264 reported | -9.3% | -1.2% | 35% | 33% | |
| Return on equityHigher is better · 246 reported | -28.6% | -3.1% | 32% | Context only | |
| Gross marginHigher is better · 278 reported | 31.8% | 37.0% | 44% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 433M USD | 99 | 81 | |
| 2 | 261M USD | 98 | 97 | |
| 3 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 3 | 356M AUD (≈$235M) | 97 | 81 | |
| 5 | 592M ILS (≈$160M) | 96 | 84 | |
| 155 | 1.6B HKD (≈$209M) | 29 | 44 | |
| 155 | 201M USD | 29 | 24 | |
| 157 | 2.7B CNY (≈$383M) | 28 | 24 | |
| 157 | 172.4B KRW (≈$124M) | 28 | 26 | |
| 157 | 221M USD | 28 | 33 | |
| 157 | 223M USD | 28 | 34 | |
| 161 | 3.1B CNY (≈$440M) | 27 | 18 | |
| 161 | 318M USD | 27 | 26 | |
| 161 | 172M USD | 27 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score